Amedeo Smart

Free Medical Literature Service


 

Amedeo

Schizophrenia

  Free Subscription

29.04.2024

2 Br J Psychiatry
2 J Psychiatry Neurosci
5 Mol Psychiatry
2 Neuropsychopharmacology
1 Psychiatry Res
4 Schizophr Res



    Br J Psychiatry

  1. FREEMAN D
    Developing psychological treatments for psychosis.
    Br J Psychiatry. 2024;224:147-149.
    >> Share

  2. FERNANDEZ-EGEA E, Chen S, Sanguesa E, Gasso P, et al
    The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
    Br J Psychiatry. 2024;224:164-169.
    >> Share


    J Psychiatry Neurosci


  3. Correction to "Improving causality perception judgments in schizophrenia spectrum disorder via transcranial direct current stimulation".
    J Psychiatry Neurosci. 2024;49:E144.
    >> Share


  4. Correction to "Navigated and individual alpha-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia".
    J Psychiatry Neurosci. 2024;49:E143.
    >> Share


    Mol Psychiatry

  5. OKADA N, Fukunaga M, Miura K, Nemoto K, et al
    Subcortical volumetric alterations in four major psychiatric disorders: a mega-analysis study of 5604 subjects and a volumetric data-driven approach for classification.
    Mol Psychiatry. 2023;28:5206-5216.
    >> Share

  6. GRIECO SF, Johnston KG, Gao P, Garduno BM, et al
    Anatomical and molecular characterization of parvalbumin-cholecystokinin co-expressing inhibitory interneurons: implications for neuropsychiatric conditions.
    Mol Psychiatry. 2023;28:5293-5308.
    >> Share

  7. WEI W, Deng L, Qiao C, Yin Y, et al
    Neural variability in three major psychiatric disorders.
    Mol Psychiatry. 2023;28:5217-5227.
    >> Share

  8. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    Selecting cases of major psychiatric and substance use disorders in Swedish national registries on the basis of clinical features to maximize the strength or specificity of the genetic risk.
    Mol Psychiatry. 2023;28:5195-5205.
    >> Share

  9. ZHENG H, Webster MJ, Weickert CS, Beasley CL, et al
    Cytomegalovirus antibodies are associated with mood disorders, suicide, markers of neuroinflammation, and microglia activation in postmortem brain samples.
    Mol Psychiatry. 2023;28:5282-5292.
    >> Share


    Neuropsychopharmacology

  10. LIVINGSTON NR, Kiemes A, Devenyi GA, Knight S, et al
    Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis.
    Neuropsychopharmacology. 2024 Apr 24. doi: 10.1038/s41386-024-01864.
    >> Share

  11. PISANU C, Congiu D, Meloni A, Paribello P, et al
    Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets.
    Neuropsychopharmacology. 2024;49:1033-1041.
    >> Share


    Psychiatry Res

  12. BRADLEY ER, Portanova J, Woolley JD, Buck B, et al
    Quantifying abnormal emotion processing: A novel computational assessment method and application in schizophrenia.
    Psychiatry Res. 2024;336:115893.
    >> Share


    Schizophr Res

  13. ALBEELY AM, Williams OOF, Blight CR, Theriault RK, et al
    Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophrenia.
    Schizophr Res. 2024;267:451-461.
    >> Share

  14. LI H, Huang Y, Liang L, Li H, et al
    The relationship between the gut microbiota and oxidative stress in the cognitive function of schizophrenia: A pilot study in China.
    Schizophr Res. 2024;267:444-450.
    >> Share

  15. LE BARS T, Bulteau S, Bonnot O, Gollier-Briant F, et al
    Home-based transcranial direct current stimulation in schizophrenia: Systematic literature review, a teenager case report with cost-utility analysis.
    Schizophr Res. 2024;267:441-443.
    >> Share

  16. GOGOS A, Sbisa A, van den Buuse M
    Disruption of NMDA receptor-mediated regulation of PPI in the maternal immune activation model of schizophrenia is restored by 17beta-estradiol and raloxifene.
    Schizophr Res. 2024;267:432-440.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016